Vancouver, British Columbia–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), Revitalist and WAKE Network, Inc. announce joint venture partnership opening psychedelic clinics and retreats with vertical offerings with a medical and therapeutic approach.
Revitalist continues to establish its presence as the premier full-service psychedelic wellness clinic offering ketamine infusions, therapy, integrative and functional medicine, teaching programs, and psychedelic wellness retreats.
Wake Network’s vertically integrated psilocybin platform includes Jamaica’s largest psilocybin mushroom facility with multiple psilocybin imports into Canada and the United States. This allows for increased access under the joint partnership with a particular focus on Oregon and Washington State. Wake’s intent to bring its proprietary culture, therapy technology and psychedelic wellness platform enables the joint partnership to be the world’s first vertically integrated psychedelic company.
Revitalist’s U.S. clinic year-to-date revenue to June 30 of US$2.43 million with over 16,000 appointments from January 1 to November 1 shows increased growth of over 300 % compared to the previous year.
Revitalist CEO Kathryn Walker says, “Partnering with Wake Network allows us to continue to effectively lead an extremely rapidly growing market. With recent market analysis reports, “Ketamine Treatment Market Size was valued at USD 132.43 Million in 2021 and is projected to grow at a CAGR of 75.52% during the forecast period, reaching USD 3871.44 million by 2027”. With healthcare experts from Revitalist and expert biotech developers from Wake, it will be exciting to see the revenue potential of this partnership. »
Wake CEO Nick Murray says, “The personalized, multi-psychedelic approach we offer through the joint partnership with Revitalist allows for greater access as well as an advanced medical approach. This will accelerate the growth of both companies internationally with combined revenues from the psilocybin, ketamine and personalized medicine markets.
About WAKE Network, Inc.
WAKE Network, Inc. is a vertically integrated, naturally occurring psilocybin bioscience company focused on advancing the field of psychedelic and mushroom therapies to address the growing need for mental health support in medicine. and in society in general. Wake currently produces mushroom-derived psilocybin and medicinal mushrooms through pharmaceutical-grade research with the goal of providing quality access to everyone through proprietary genomic and biomarker processes.
About Revitalist Lifestyle and Wellness, Ltd.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is one of the largest publicly traded ketamine-focused clinical operations in the United States. Each clinic provides access to psychedelic medicine, vitamin infusions and other lifestyle optimization services provided by health and behavioral professionals. Since opening its first clinic in 2018, Revitalist has provided thousands of ketamine infusions through its network of 9 clinics operating in 6 states. Its founder and CEO, Kathryn Walker, works as a primary provider in the psychedelic space as an advanced behavioral and medical provider. For more information, please visit Revitalist.com.
On behalf of the board
Chief executive officer
This press release contains forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause Revitalist’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements or information. contents in this press release.
#Revitalist #Wake #Network #Announce #Joint #Venture #Partnership #Open #Psychedelic #Clinics #Retreats #United #States